Literature DB >> 9157591

Prevalence of factor V Leiden mutation in non-European populations.

G Pepe1, O Rickards, O C Vanegas, T Brunelli, A M Gori, B Giusti, M Attanasio, D Prisco, G F Gensini, R Abbate.   

Abstract

A difference in the prevalence of venous thromboembolism (TE) in major human groups has been described and an uneven distribution of FV Leiden mutation over the world has recently been reported. We investigated FV Leiden mutation in 584 apparently healthy subjects mostly from populations different from those previously investigated: 170 Europeans (Spanish, Italians), 101 sub-saharan Africans (Fon, Bariba, Berba, Dendi), 115 Asians (Indonesians, Chinese, Tharus), 57 Amerindians (Cayapa), 84 Afroamericans (Rio Cayapa, Viche), and 57 Ethiopians (Amhara, Oromo). The mutation was detected in only 1/115 Asian (Tharu) and in 5/170 Europeans (4 Italians, 1 Spanish). These data confirm that in non-Europeans the prevalence of FV mutation is at least 7 times lower than in Europeans and provide indirect evidence of a low prevalence not only of the FV Leiden gene but also of other genes leading to more severe thrombophilia. Finally, findings from the literature together with those pertaining to this study clearly show a marked heterogeneity among Europeans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9157591

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels.

Authors:  Todor Arsov; Daniela Miladinova; Mirko Spiroski
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

2.  Polymorphisms in Factor II and Factor V thrombophilia genes among Circassians in Jordan.

Authors:  R Dajani; A Arafat; N Hakooz; Z Al-Abbadi; Al-Motassem Yousef; M El Khateeb; F Quadan
Journal:  J Thromb Thrombolysis       Date:  2013-01       Impact factor: 2.300

3.  Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals.

Authors:  Ali A Dashti; Mehrez M Jadaon
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

Review 4.  Challenges in the diagnosis and treatment of pediatric stroke.

Authors:  Lori C Jordan; Argye E Hillis
Journal:  Nat Rev Neurol       Date:  2011-03-08       Impact factor: 42.937

5.  Association between congenital thrombophilia and outcomes in pulmonary embolism patients.

Authors:  Tian-Yu Lian; Dan Lu; Xin-Xin Yan; Jiang-Shan Tan; Fu-Hua Peng; Yong-Jian Zhu; Yun-Peng Wei; Tao Wu; Kai Sun; Xin Jiang; Lu Hua; Zhi-Cheng Jing
Journal:  Blood Adv       Date:  2020-12-08

6.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

7.  Mechanical thromboprophylaxis is sufficient to prevent the lower extremity deep vein thrombosis after kidney transplantation.

Authors:  Kang-Woong Jun; Keun-Myoung Park; Mi-Hyeong Kim; Jeong-Kye Hwang; Soon-Chul Park; In-Sung Moon; Byung-Ha Chung; Bum-Soon Choi; Chul-Woo Yang; Yong-Soo Kim; Ji-Il Kim
Journal:  Ann Surg Treat Res       Date:  2014-06-24       Impact factor: 1.859

8.  Factor V Leiden Mutation Frequency and Geographical Distribution in Turkish Population.

Authors:  Eray Yıldız; Funda Müşerref Türkmen
Journal:  J Transl Int Med       Date:  2020-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.